Featured Publications
Pulmonary Toxicities from Checkpoint Immunotherapy for Malignancy
Possick JD. Pulmonary Toxicities from Checkpoint Immunotherapy for Malignancy. Clinics In Chest Medicine 2017, 38: 223-232. PMID: 28477635, DOI: 10.1016/j.ccm.2016.12.012.Chapters
2018
Should Physicians New to a Case Counsel Patients and Their Families to Change Course at the End of Life?
Honiden S, Possick J. Should Physicians New to a Case Counsel Patients and Their Families to Change Course at the End of Life? The AMA Journal Of Ethic 2018, 20: e699-707. PMID: 30118419, DOI: 10.1001/amajethics.2018.699.Commentaries, Editorials and LettersConceptsGoals of careLife care optionsPhysician practice variationEnd of lifeAdvanced malignanciesCounsel patientsCritical illnessOncology patientsNew cancer therapiesCare discussionsIndividual patientsPractice variationCare plansComfort measuresPhysician objectionPatientsCare optionsPhysiciansCancer therapyClinical momentumPotential benefitsPrognosisMalignancyTherapyIllness